Cardiotoxic effects of doxorubicin with and without carnitine. Usefulness of the mouse model in assessment

G. H. Strohm, C. M. Payne, David S Alberts

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A mouse model of long-term doxorubicin hydrochloride (Adriamycin) toxicity, which demonstrated significantly longer survival when carnitine is administered simultaneously with doxorubicin, was evaluated by electron microscopic and biochemical study of cardiac muscle to correlate ultrastructural and metabolic changes with survival. One hundred Balb/C mice were randomly divided into four groups: control, carnitine, doxorubicin-carnitine, and doxorubicin alone. Significantly improved survival occurred in the doxorubicin-carnitine group when compared with the group receiving doxorubicin alone, in two separate experiments. However, there were no statistically significant differences in cardiac ultrastructure, carnitine concentration, or palmitate oxidation rates between treatment and control groups. The results indicate that although the mouse is useful for study of survival related to doxorubicin toxicity and combination drug therapies, it does not seem to be suitable for evaluation of ultrastructural changes related to longterm doxorubicin cardiotoxicity.

Original languageEnglish (US)
Pages (from-to)181-185
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume106
Issue number4
StatePublished - 1982

Fingerprint

Carnitine
Doxorubicin
Control Groups
Palmitates
Combination Drug Therapy
Myocardium
Electrons

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Cardiotoxic effects of doxorubicin with and without carnitine. Usefulness of the mouse model in assessment. / Strohm, G. H.; Payne, C. M.; Alberts, David S.

In: Archives of Pathology and Laboratory Medicine, Vol. 106, No. 4, 1982, p. 181-185.

Research output: Contribution to journalArticle

@article{bd60b63d630347a2aeceefdc8df89716,
title = "Cardiotoxic effects of doxorubicin with and without carnitine. Usefulness of the mouse model in assessment",
abstract = "A mouse model of long-term doxorubicin hydrochloride (Adriamycin) toxicity, which demonstrated significantly longer survival when carnitine is administered simultaneously with doxorubicin, was evaluated by electron microscopic and biochemical study of cardiac muscle to correlate ultrastructural and metabolic changes with survival. One hundred Balb/C mice were randomly divided into four groups: control, carnitine, doxorubicin-carnitine, and doxorubicin alone. Significantly improved survival occurred in the doxorubicin-carnitine group when compared with the group receiving doxorubicin alone, in two separate experiments. However, there were no statistically significant differences in cardiac ultrastructure, carnitine concentration, or palmitate oxidation rates between treatment and control groups. The results indicate that although the mouse is useful for study of survival related to doxorubicin toxicity and combination drug therapies, it does not seem to be suitable for evaluation of ultrastructural changes related to longterm doxorubicin cardiotoxicity.",
author = "Strohm, {G. H.} and Payne, {C. M.} and Alberts, {David S}",
year = "1982",
language = "English (US)",
volume = "106",
pages = "181--185",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - Cardiotoxic effects of doxorubicin with and without carnitine. Usefulness of the mouse model in assessment

AU - Strohm, G. H.

AU - Payne, C. M.

AU - Alberts, David S

PY - 1982

Y1 - 1982

N2 - A mouse model of long-term doxorubicin hydrochloride (Adriamycin) toxicity, which demonstrated significantly longer survival when carnitine is administered simultaneously with doxorubicin, was evaluated by electron microscopic and biochemical study of cardiac muscle to correlate ultrastructural and metabolic changes with survival. One hundred Balb/C mice were randomly divided into four groups: control, carnitine, doxorubicin-carnitine, and doxorubicin alone. Significantly improved survival occurred in the doxorubicin-carnitine group when compared with the group receiving doxorubicin alone, in two separate experiments. However, there were no statistically significant differences in cardiac ultrastructure, carnitine concentration, or palmitate oxidation rates between treatment and control groups. The results indicate that although the mouse is useful for study of survival related to doxorubicin toxicity and combination drug therapies, it does not seem to be suitable for evaluation of ultrastructural changes related to longterm doxorubicin cardiotoxicity.

AB - A mouse model of long-term doxorubicin hydrochloride (Adriamycin) toxicity, which demonstrated significantly longer survival when carnitine is administered simultaneously with doxorubicin, was evaluated by electron microscopic and biochemical study of cardiac muscle to correlate ultrastructural and metabolic changes with survival. One hundred Balb/C mice were randomly divided into four groups: control, carnitine, doxorubicin-carnitine, and doxorubicin alone. Significantly improved survival occurred in the doxorubicin-carnitine group when compared with the group receiving doxorubicin alone, in two separate experiments. However, there were no statistically significant differences in cardiac ultrastructure, carnitine concentration, or palmitate oxidation rates between treatment and control groups. The results indicate that although the mouse is useful for study of survival related to doxorubicin toxicity and combination drug therapies, it does not seem to be suitable for evaluation of ultrastructural changes related to longterm doxorubicin cardiotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=0020056558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020056558&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0020056558

VL - 106

SP - 181

EP - 185

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -